Dubai, June 2016
Advance Analytical Technologies, Inc., (AATI Ankeny, IA) signed an exclusive distribution agreement with the AGBL Group (Dubai, UAE) to bring AATI automated capillary electrophoresis instruments solution to AGBL Group’s markets.
“Being able to offer our customers the AATI CE-based technology for biomolecules analysis will enable them to expand their high throughput next-generation sequencing work. AATI’s Fragment Analyzer is in fact the perfect solution for “laborious and time-consuming” work being done in many of our customers’ labs, and being able to automate fragmentation and size selection will help our customers greatly. The technologies and products offered by AATI fit our customers’ needs and complement AGBL’s Life science portfolio”, says Dr. Simona Maciotta, Product manager at Alliance Global.
About AATI
Advanced Analytical Technologies, Inc., (AATI) develops, manufactures, and markets low and high-throughput, fully-automated nucleic acid genetic analysis systems. AATI platforms optimize and accelerate complex genomics workflows for basic science and commercial applications in multiple life science industries including: genomics, molecular diagnostics, pharmaceuticals, healthcare, biotechnology, synthetic biology, biofuels, and agriculture. The company’s product portfolio has instruments for parallel analysis of DNA, RNA, pharmaceutical compounds, and proteins using capillary electrophoresis (CE) with fluorescence or UV absorbance detection. The Fragment Analyzer™ is AATI’s flagship platform recognized as the best-in-class multi-channel automated fluorescence-based CE detection system. Advanced Analytical has facilities in Ankeny, Iowa, USA and Heidelberg, Germany. More information is available at- http://www.aati-us.com